February 3, 2024
Intellectual Property | Patent
Intellectual Property | Patent
Patentability of Graphical User Interfaces in India
Graphical User Interfaces (GUIs) are no longer just basic interfaces; but are an integral component of the user experience. From AI powered chatbots that assist a user, to virtual reality experiences, there have been significant innovations in this field. Globally, the number of patent applications published in the field of GUIs has nearly doubled in the past three years, with over 20,000 published in 2023 alone. ......
February 1, 2024
Intellectual Property | Patent
Intellectual Property | Patent
Filing Patents of Addition abroad also requires Foreign...
Filing a patent in your home jurisdiction is merely the beginning of building a patent portfolio. Depending on the subject matter of the patent, and the business model, it would be strategic to also file related patents abroad. ......
January 30, 2024
Intellectual Property | Trademark
Intellectual Property | Trademark
Food for Thought: IP Protection in the Indian Food Indu...
Food is a language that connects everyone worldwide. Cuisines change every few hundred miles, food habits and preferences vary with the climate, and families have their own culinary secrets that get passed on from generation to generation. Everyone has something to share and protect. ......
January 25, 2024
Intellectual Property | Patent
Intellectual Property | Patent
Draft Patent Rules 2024 – Decriminalizing Offences
In the last few years, the Indian government has taken various steps to reform the patent filing process in India and strengthen the Indian IP ecosystem. In the latest series of developments, the Ministry of Commerce and Industry (“MoCI”) published draft Patents (2nd Amendment) Rules, 2024 (“the draft Rules") on January 2, 2024, seeking comments from the public and/or any stakeholders. Public comments to the draft Rules are invited until February 2, 2024. ......
November 21, 2023
Intellectual Property | Patent
Intellectual Property | Patent
Divisive no longer: Delhi HC clarifies contrary views o...
A Division Bench of the Delhi High Court has brought much-required clarity on filing of divisional applications in India, which at least two different single judge benches of the same court had disagreed upon previously. ......
August 17, 2023
Intellectual Property | Patent
Intellectual Property | Patent
Patenting a ‘mere discovery’ or ‘something altogether n...
When is a new product considered a mere discovery of something that subsists in nature and thus unpatentable, and when is it altogether new or unfamiliar, and thus, worthy of being granted a patent? This is the question that the Delhi High Court tackled in the recent case of Diamond Star Global SDN BHD v Joint Controller of Patents. ......
August 2, 2023
Intellectual Property
Intellectual Property
ITS A BARBIE WORLD: MATTEL AND THE FUNDAMENTALS OF INTE...
From an iconic toy, a mainstay for children around the world for decades, to an economic powerhouse in her own right, Barbie is undoubtedly an iconic pop culture figure. Created by Ruth Handler, the co-founder of Mattel Inc. ("Mattel"), after coming across Bild Lilli, a popular German novelty toy first created in 1952, while on a family vacation in Switzerland in 1956. ......
July 20, 2023
Intellectual Property | Patent
Intellectual Property | Patent
Experiments with Animals: The long road to preventing a...
Over 100 million animals are used in laboratory experiments worldwide every year. These are only estimates; the exact number is unknown and could possibly even be higher. These animals are either killed outright in scientific procedures, or used to assess the safety and efficacy of drugs and cosmetics. ......
July 3, 2023
Intellectual Property | Patent
Intellectual Property | Patent
When medicines are out of reach: Managed Access Program...
Before a new drug, biologic or medical device is approved and authorized for market launch, it has to undergo a long and complex process involving extensive testing and clinical trials to ensure its safety and efficacy. However, for patients who have exhausted all other options, sometimes an unapproved or pre-approved or investigational drug could be the only hope. ......









